1. Home
  2. YMAB vs BSRR Comparison

YMAB vs BSRR Comparison

Compare YMAB & BSRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YMAB
  • BSRR
  • Stock Information
  • Founded
  • YMAB 2015
  • BSRR 1977
  • Country
  • YMAB United States
  • BSRR United States
  • Employees
  • YMAB N/A
  • BSRR N/A
  • Industry
  • YMAB Biotechnology: Pharmaceutical Preparations
  • BSRR Major Banks
  • Sector
  • YMAB Health Care
  • BSRR Finance
  • Exchange
  • YMAB Nasdaq
  • BSRR Nasdaq
  • Market Cap
  • YMAB 482.4M
  • BSRR 444.7M
  • IPO Year
  • YMAB 2018
  • BSRR 1994
  • Fundamental
  • Price
  • YMAB $6.19
  • BSRR $29.89
  • Analyst Decision
  • YMAB Strong Buy
  • BSRR Hold
  • Analyst Count
  • YMAB 10
  • BSRR 2
  • Target Price
  • YMAB $21.10
  • BSRR $35.00
  • AVG Volume (30 Days)
  • YMAB 417.3K
  • BSRR 52.3K
  • Earning Date
  • YMAB 02-27-2025
  • BSRR 01-27-2025
  • Dividend Yield
  • YMAB N/A
  • BSRR 3.20%
  • EPS Growth
  • YMAB N/A
  • BSRR 4.47
  • EPS
  • YMAB N/A
  • BSRR 2.52
  • Revenue
  • YMAB $84,553,000.00
  • BSRR $143,689,000.00
  • Revenue This Year
  • YMAB $6.09
  • BSRR N/A
  • Revenue Next Year
  • YMAB $19.62
  • BSRR $2.66
  • P/E Ratio
  • YMAB N/A
  • BSRR $11.67
  • Revenue Growth
  • YMAB N/A
  • BSRR 4.68
  • 52 Week Low
  • YMAB $6.01
  • BSRR $17.69
  • 52 Week High
  • YMAB $20.90
  • BSRR $35.13
  • Technical
  • Relative Strength Index (RSI)
  • YMAB 19.68
  • BSRR 53.70
  • Support Level
  • YMAB $6.05
  • BSRR $27.06
  • Resistance Level
  • YMAB $6.81
  • BSRR $30.37
  • Average True Range (ATR)
  • YMAB 0.49
  • BSRR 0.99
  • MACD
  • YMAB -0.02
  • BSRR 0.19
  • Stochastic Oscillator
  • YMAB 6.90
  • BSRR 85.50

About YMAB Y-mAbs Therapeutics Inc.

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.

About BSRR Sierra Bancorp

Sierra Bancorp is a California-based bank holding company, which offers a range of retail and commercial banking services. it offers a wide range of deposit products and services for individuals and businesses including checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts, and sweep accounts. The company's lending activities cover real estate, commercial (including small business), mortgage warehouse, agricultural, and consumer loans, and also offers commercial construction loans and multifamily and agricultural credit facilities among other types of real estate loans.

Share on Social Networks: